>
  info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Creatinine Test Companies

Creatinine test companies are involved in the development and provision of diagnostic tests and services to measure creatinine levels in the blood and urine. Creatinine is a waste product produced by muscles and eliminated by the kidneys, and its measurement is critical in assessing kidney function and other medical conditions.

Creatinine Test  Key CompaniesDisclaimer: List of key companies in no particular orderLatest Creatinine test Companies Update



  • Aug 2023: According to Mindray Bio-Medical Electronics, the Chinese medical equipment manufacturer would invest EUR145 million (USD159 million) in buying a controlling stake in DiaSys Diagnostic Systems and increase the German company's capital. This move will enhance the Chinese company's international business structure and product competitiveness. The parent company of Mindray Medical Netherlands, located in Shenzhen, announced late yesterday that it had signed two agreements with Gorka Holding, a shareholder in DiaSys Diagnostic, to purchase 75% of the firm's in-vitro diagnostics services and goods for EUR115 million in cash on July 29. Gorka will keep the remainder. It further stated that Mindray and Gorka would contribute EUR40 million (USD43.9 million) to the capital expansion of DiaSys Diagnostic, with the Chinese company contributing EUR30 million. According to Mindray, the acquisition will help it develop medium- and large-volume sample clients, bring in a top international team for in-vitro diagnostics, strengthen product competitiveness, and improve collaboration between its in-vitro testing, quality assurance, and calibration products.


List of Creatinine test Key companies in the market

  • Abbott Laboratories

  • Abcam Plc

  • Acon Laboratories, Inc.

  • Nova Biomedical Corporation

  • Quest Diagnostic

  • Siemens AG

  • Thermo Fisher Scientific Inc.

  • Roche

  • Danaher Corporation.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.